Matt’s reporting on the politics and business of cancer research and drug development has led to Congressional investigations, triggered action by FDA, CDC, NIH, NCI, FBI, and GAO, and helped change policy and standards of care.
Disclosures: Matt is an MPH, Epidemiology candidate at the Harvard T.H. Chan School of Public Health.
His work has received more than 25 awards and is recognized by more than 15 organizations, including the National Press Club, Society of Professional Journalists, Association of Health Care Journalists, The Poynter Institute, Society of American Business Editors and Writers, National Institute for Health Care Management Foundation, American Society of Business Publication Editors, American Association of University Professors, the Washington Media Institute, and Washington, D.C. Chapter of the Society of Professional Journalists.
His stories have been picked up and cited in books, journals, and by media organizations, including The Washington Post, The Wall Street Journal, The New York Review of Books, ABC News, CBS affiliates, The Boston Globe, Science, Nature, Inside Higher Ed, The Houston Chronicle, The Philadelphia Inquirer, The Journal of the American Medical Association, The British Medical Journal, The American Journal of Managed Care, and by the President’s Cancer Panel, CEO Roundtable on Cancer, CEO Cancer Life Sciences Consortium, and the American Association for Cancer Research. He has been interviewed for documentaries, podcasts, and on public radio programs, including NPR.
Matt serves as an instructor and guest speaker for policy and advocacy organizations, at conferences, as well as at D.C.-area universities and research institutions.
He is one of five journalists selected for the 2021 class of the Health Care Performance Fellowship, the Association of Health Care Journalists' most prestigious fellowship, which is supported by The Commonwealth Fund. In 2022, he was selected as an NIH Research Scholar with the NIH All of Us Research Program.
In 2020, he was selected from over 130 journalists by the Poynter Institute and The Washington Post to join the 2020-21 Leadership Academy for Diversity in Digital Media. He was also chosen as a fellow for AHCJ’s inaugural 2016 class of the National Cancer Reporting Fellowships at the National Cancer Institute, and the 2017 Comparative Effectiveness Research Fellowship at the Patient-Centered Outcomes Research Institute.
Matt graduated from Marquette University in 2012, majoring in journalism, psychology, as well as women’s and gender studies. His CV is available on www.matthewong.com.
Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled
A year ago, Renee Wegrzyn signed up for a very cool job. As the inaugural director of the Advanced Research Projects Agency for Health, she was to prove that the nontraditional, $2.5 billion experiment will yield the kind of high impact its high-risk investment model promises. Since Wegrzyn joined the agency in October 2022, ARPA-H has...
The standard of care in HPV vaccination may soon change if a one-dose regimen is found to be just as efficacious as two or three doses—once a large trial that NCI is conducting in Costa Rica, in young women ages 12 to 16, is ready to report final results in a few years. “We’ve done...
NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance”
Professional societies are implementing measures to limit transmission of SARS-CoV-2 at conferences, as oncology groups reconvene in-person annual meetings for the first time since early 2020. The American Society of Clinical Oncology will require proof of vaccination, encourage indoor masking, and provide masks onsite—regardless of mandates and regulations—at its upcoming annual meeting June 3-7 in...